<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03864315</url>
  </required_header>
  <id_info>
    <org_study_id>201403043DINC</org_study_id>
    <nct_id>NCT03864315</nct_id>
  </id_info>
  <brief_title>To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study</brief_title>
  <official_title>To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators demonstrated that in vivo THG microscopy can differentiate&#xD;
      vitiligo lesions and normal skin based the optical nature of melanin. This THG-based&#xD;
      procedure provides a valuable tool for noninvasive determination of third-order nonlinear&#xD;
      susceptibility of melanin within the skin. It can also provide real-time histopathology&#xD;
      information for treatment follow-up, without performing invasive skin biopsy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators initiate this open, randomized, left-right comparative study to evaluate&#xD;
      the efficacy of pulsed ultrasound in the treatment of vitiligo on the face or trunk. Face is&#xD;
      included in this study because vitiliginous lesions on the face has a better treatment&#xD;
      response and causes more psychological distress on the patients than vitiligo affecting other&#xD;
      body areas. Thirty adult subjects with vitiligo affecting the face or trunk symmetrically&#xD;
      will be recruited. After randomization, subjects will be administrated their ulrasound&#xD;
      treatment twice a week for 24 weeks. Their original topical treatment and/or phototherapy&#xD;
      will be continued. During follow-up visits, digital photographs will be taken for evaluating&#xD;
      the extent of residual depigmentation. In vivo harmonic microscopy and three skin biopsy&#xD;
      specimens will be performed at the indicated time points on the depigmented, repigmented&#xD;
      areas and surrounding normal skin.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2014</start_date>
  <completion_date type="Actual">December 9, 2015</completion_date>
  <primary_completion_date type="Actual">October 23, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>30 participants with Vitiligo as assessed by Harmonic Generation Microscopy.</measure>
    <time_frame>1-2 hours per case</time_frame>
    <description>The HGM system will be combined to provide the noninvasive microscopic images in Vitiligo sites during each follow-up for pathological diagnosis.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Vitiligo</condition>
  <arm_group>
    <arm_group_label>Vitiligo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 Patients with Vitiligo</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HGM</intervention_name>
    <description>To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study</description>
    <arm_group_label>Vitiligo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 20-75 years old&#xD;
&#xD;
          2. With skin type Ⅲ or Ⅳ&#xD;
&#xD;
          3. With Vitiligo&#xD;
&#xD;
          4. Can read the informed consent form&#xD;
&#xD;
          5. Can continue the original treatments&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. With segmental vitiligo.&#xD;
&#xD;
          2. Have joined other clinical trials&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi-Hua Liao</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 25, 2019</study_first_submitted>
  <study_first_submitted_qc>March 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2019</study_first_posted>
  <last_update_submitted>March 4, 2019</last_update_submitted>
  <last_update_submitted_qc>March 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitiligo</keyword>
  <keyword>Harmonic Generation Microscopy</keyword>
  <keyword>In Vivo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitiligo</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

